KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Intangibles (2016 - 2025)

Zimmer Biomet Holdings has reported Intangibles over the past 17 years, most recently at $4.7 billion for Q4 2025.

  • Quarterly results put Intangibles at $4.7 billion for Q4 2025, up 2192.18% from a year ago — trailing twelve months through Dec 2025 was $4.7 billion (up 2192.18% YoY), and the annual figure for FY2025 was $4.7 billion, up 2192.18%.
  • Intangibles for Q4 2025 was $4.7 billion at Zimmer Biomet Holdings, roughly flat from $4.7 billion in the prior quarter.
  • Over the last five years, Intangibles for ZBH hit a ceiling of $9.1 billion in Q4 2021 and a floor of $33.0 million in Q1 2024.
  • Median Intangibles over the past 5 years was $4.7 billion (2025), compared with a mean of $3.5 billion.
  • Biggest five-year swings in Intangibles: tumbled 99.35% in 2024 and later surged 13439.39% in 2025.
  • Zimmer Biomet Holdings' Intangibles stood at $9.1 billion in 2021, then crashed by 94.94% to $459.1 million in 2022, then crashed by 81.25% to $86.1 million in 2023, then soared by 139.02% to $205.8 million in 2024, then skyrocketed by 2192.18% to $4.7 billion in 2025.
  • The last three reported values for Intangibles were $4.7 billion (Q4 2025), $4.7 billion (Q3 2025), and $4.9 billion (Q2 2025) per Business Quant data.